Cardiovascular risk to be considered. Proinsulin test for stage-adjusted therapy
MMW Fortschritte der Medizin 147(10): 49
2005
ISSN/ISBN: 1438-3276 PMID: 15803786 Document Number: 590707
Document emailed within 1 workday
Related Documents
Frobenius, W.; Tulusan, A.H.; Lang, N. 1994: Stage adjusted therapy of malignancies and breast cancers Geburtshilfe und Frauenheilkunde 54(4): M51-M56Mercuro, G.; Zoncu, S.; Cherchi, A.; Rosano, G.M. 2001: Can menopause be considered an independent risk factor for cardiovascular disease? Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 2(10): 719-727
Fellah, H.; Feki, M.; Feki, H.; Souissi, M.; Kaabachi, N.; Abdallah, T.B.; Massy, Z.A.; Maiz, H.B.; Lacour, B.; Mebazaa, A. 2004: Classical and "Non-classical" Cardiovascular Risk Factors in Tunisian Patients with End Stage Renal Disease: Prevalence and Association with Cardiovascular Events Clinical Laboratory 50(7-8): 447-453
Seagroatt, V. 1997: Impact of postmenopausal hormone therapy on cardiovascular events and cancer. Paper's main conclusion is no longer justified when data from all trials are considered Bmj 315(7109): 677; Author Reply 678-9
Yue, M.; Zhang, H.; Li, R. 2016: Meta-analysis on the risk of all-cause mortality and cardiovascular death in the early stage of hypertension Pakistan Journal of Pharmaceutical Sciences 29(4 Suppl): 1343-1351
Wu, T.J.; Huang, S.M.; Taylor, R.L.; Kao, P.C. 1998: Abnormal proinsulin levels in thyroid dysfunction measured by a sensitive proinsulin immunochemiluminoassay Annals of Clinical and Laboratory Science 28(2): 82-87
Starr, J.I.; Mako, M.E.; Juhn, D.; Rubenstein, A.H. 1978: Measurement of serum proinsulin-like material: cross-reactivity of porcine and human proinsulin in the insulin radioimmunoassay Journal of Laboratory and Clinical Medicine 91(4): 683-692
Del Arbol, J.L.; Jiménez-Alonso, J.; García Romero, E.; Osorio, J.; Peña Yañez, A. 1979: Hyperinsulinism due to hyperplasia of pancreatic beta cells. Value of proinsulin determination and of the somatostatin-tolbutamide test Revista Clinica Espanola 152(3): 239-242
Bailit, J.L.; Schulkin, J.; Dawson, N.V. 2007: Risk-adjusted cesarean rates: what risk factors for cesarean delivery are important to practicing obstetricians? Journal of Reproductive Medicine 52(3): 194-198
Baena Díez, Jé.Miguel.; Del Val García, Jé.Luis.; Alemany Vilches, L.; Martínez Martínez, Jé.Luis.; Tomàs Pelegrina, J.; González Tejón, Ián.; Raidó Quintana, E.María.; Rovira España, Mónica. 2005: Risk of Suffering from Cardiovascular Diseases because of the Clustering of the Modifiable Cardiovascular Risk Factors in the Population Older than 15 years of a Health Care Center in Barcelona Revista espanola de salud publica 79: 365-378
Kleber, M.E.; Winkler, K.; Wolfert, R.L.; Delgado, G. de Moissl; Grammer, T.B.; Dietz, S.; Winkelmann, B.R.; Boehm, B.O.; Winfried März 2011: Lipoprotein Associated Phospholipase A2 Concentration Predicts Total and Cardiovascular Mortality Independently of Established Risk Factors (The Ludwigshafen Risk and Cardiovascular Health Study) Clinical Laboratory 57(9-10): 659-667
Osler, M.; Jespersen, N.B.; Lous, J.; Rasmussen, N.K. 1992: Cardiovascular risk factors--extent and self-assessed risk in relation to prevention of cardiovascular diseases. A questionnaire among 3,956 men and women aged 24-65 years in Vejle County, Slangerup and Helsinge municipalities Ugeskrift for Laeger 154(9): 538-543
Rees, J. 2015: Androgen deprivation therapy and cardiovascular risk Practitioner 259(1785): 5
VandeKieft, G. 1996: Postmenopausal hormone therapy and cardiovascular risk Journal of Family Practice 43(5): 437-438
Smith, S.C. 1997: The challenge of risk reduction therapy for cardiovascular disease American Family Physician 55(2): 491-500
Perna, A. 2008: Folate therapy for prevention of cardiovascular risk in uremia Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 25(3): 273
Alexander, H.; Bartlett, A.; Poole, G. 2016: Reporting risk-adjusted outcomes for surgical procedures in New Zealand New Zealand Medical Journal 129(1430): 96-97
Simon, T.; Jaillon, P. 2001: Hormone replacement therapy and cardiovascular risk in menopausal women Archives des Maladies du Coeur et des Vaisseaux 94(2): 132-138
Herpin, D.; Ferrandis, J.; Gaudeau, B.; Ragot, S.; Le Henaff, J.; Raud, P.; Amiel, A.; Demange, J. 1995: Coronary artery disease in hypertensive patients: improvement of the diagnostic value of exercise test by heart rate adjusted ST segment depression Archives des Maladies du Coeur et des Vaisseaux 88(8): 1129-1133
Kuttenn, F.; Gerson, M.; de Lignères, B. 2002: Effects of hormone replacement therapy in menopause on cardiovascular risk. Need for a European study Presse Medicale 31(10): 468-475